Published 28 Sep 2022 appoints Dr. Shibu Vijayan as Medical Director – Global Health



The new posting reiterates's efforts to strengthen its strategic offerings and accelerate global expansion in the public healthcare sector., a leading health tech provider, has appointed renowned global health expert, Dr. Shibu Vijayan as its Medical Director for Global Health Practice. The company enjoys clear leadership in the global health space and the new addition of Dr Vijayan to its helm will bolster its partnerships with strategic change-makers in public health, manifold.  
Dr. Vijayan is a senior clinician in Community and Public Health Services. He has 25 years of experience in developing, monitoring, and evaluating public health projects, including developing healthcare-related proposals in both private and not-for-profit organizations. He is also an accredited International general Tuberculosis (TB) expert by the TB team hosted by WHO and Stop TB Partnership.
Prior to, he was at PATH and has also worked with the WHO as Technical Consultant for the TB Control Program in India and was associated with Medicines Sans Frontiers (MSF, Netherlands) as a field Epidemiologist in Ethiopia.
Commenting on the announcement, Prashant Warier, Founder and CEO,, said, “Dr. Vijayan comes with an enviable trove of experience, varied across the public health spectrum. He has been one of our long-standing supporters and was one of the first people to adopt qXR for TB in the Global Health community. We are delighted to welcome him as one of our own and continue our journey to improve healthcare outcomes for disadvantaged populations globally. With him at the helm of our global health portfolio, I am positive that will strengthen our leadership position in the application of AI solutions to deliver affordable and accessible healthcare for everyone". 
“Qure’s AI and digital solutions are targeted towards accelerating Universal Health Coverage. This dynamic team is doing stellar work towards improving global healthcare access and I am excited to be part of the journey. We will continue to strive towards optimizing global health practices and expand our footprint further to reach remote communities and their unmet medical needs”, said Dr Shibu Vijayan, Medical Director, Global Health,'s global health presence has been on a steady growth path. The company has increased its impact manifold during the last two years and has touched over 12 million lives across the world’s most vulnerable populations.'s intervention during the pandemic and the continued efforts to optimize lung health screening in vulnerable communities has been a distinguisher across markets.   
The company is one of the leading AI solutions providers to be recommended by WHO, in the absence of a human reader. is present in 600+ sites across 60+ countries, including the UK, US, Southeast Asia, Latin America, Australia, and Africa.

Share this story